Literature DB >> 3292364

Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis.

F Lozano1, A Parés, L Borche, M Plana, T Gallart, J Rodés, J Vives.   

Abstract

An antinuclear immunofluorescence pattern displaying a thin ring confined to the nuclear envelope was assessed in sera from 38 patients with primary biliary cirrhosis and in sera from a control group of 277 patients with other antinuclear antibody-positive diseases. This rim-like antinuclear reactivity was present in sera from 20 primary biliary cirrhosis patients (52.6%) but in only two patients from the control group (0.7%) (p less than 0.001). Furthermore, this autoantibody was present in three of four primary biliary cirrhosis patients without antimitochondrial antibodies. Presence of this rim-like pattern in primary biliary cirrhosis did not correlate with the presence of associated autoimmune diseases nor with other clinical, biochemical, nor histological features of the disease. The antigenic specificity of sera displaying this antinuclear immunofluorescence pattern was characterized by Western blot analysis using an antigenic extract containing nuclear envelope proteins purified from rat liver. Sixteen of the 20 positive sera showed a common pattern of reactivity with a set of nuclear envelope-associated proteins approximately 200 kD in size. In conclusion, sera from primary biliary cirrhosis patients showing a rim-like fluorescent nuclear pattern have antinuclear autoantibodies that react specifically with components of the nuclear envelope. The high specificity of these new autoantibodies in primary biliary cirrhosis indicate that they might be a serological marker of the disease, particularly useful in patients without antimitochondrial antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292364     DOI: 10.1002/hep.1840080438

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 2.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

3.  The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.

Authors:  J C Courvalin; K Lassoued; E Bartnik; G Blobel; R W Wozniak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Authors:  Gideon M Hirschfield; Jessica K Dyson; Graeme J M Alexander; Michael H Chapman; Jane Collier; Stefan Hübscher; Imran Patanwala; Stephen P Pereira; Collette Thain; Douglas Thorburn; Dina Tiniakos; Martine Walmsley; George Webster; David E J Jones
Journal:  Gut       Date:  2018-03-28       Impact factor: 23.059

5.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 6.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 7.  Autoantigens of the nuclear pore complex.

Authors:  P Enarson; J B Rattner; Y Ou; K Miyachi; T Horigome; M J Fritzler
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

8.  Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.

Authors:  Florent Valour; Stéphane Durupt; Safia Khenifer; Isabelle Durieu
Journal:  BMJ Case Rep       Date:  2013-06-26

9.  Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.

Authors:  Alicja Bauer; Andrzej Habior
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

10.  Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.

Authors:  A Muñoz; T Gallart; E F Usac; J Fernández-Alvarez; O Viñas; N Somoza; J Barceló; R Gomis
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.